nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—UGCG—nephron tubule—kidney cancer	0.0291	0.104	CbGeAlD
Miglustat—GBA2—renal system—kidney cancer	0.0269	0.096	CbGeAlD
Miglustat—UGCG—renal system—kidney cancer	0.0265	0.0946	CbGeAlD
Miglustat—GBA2—kidney—kidney cancer	0.026	0.0928	CbGeAlD
Miglustat—UGCG—kidney—kidney cancer	0.0256	0.0915	CbGeAlD
Miglustat—GBA2—cortex of kidney—kidney cancer	0.0253	0.0904	CbGeAlD
Miglustat—UGCG—cortex of kidney—kidney cancer	0.0249	0.0891	CbGeAlD
Miglustat—GBA2—gonad—kidney cancer	0.0241	0.0861	CbGeAlD
Miglustat—GBA2—cardiac atrium—kidney cancer	0.0241	0.086	CbGeAlD
Miglustat—UGCG—gonad—kidney cancer	0.0238	0.0849	CbGeAlD
Miglustat—UGCG—cardiac atrium—kidney cancer	0.0237	0.0847	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—RELA—kidney cancer	0.00571	0.0439	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MTOR—kidney cancer	0.0056	0.0431	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—IL2—kidney cancer	0.00514	0.0396	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00408	0.0314	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYC—kidney cancer	0.00402	0.0309	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00374	0.0287	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PIK3CA—kidney cancer	0.00341	0.0263	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ACY1—kidney cancer	0.00262	0.0202	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ACY1—kidney cancer	0.0024	0.0185	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00224	0.0172	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PDHB—kidney cancer	0.00223	0.0172	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CCBL1—kidney cancer	0.0021	0.0161	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00205	0.0157	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PDHB—kidney cancer	0.00204	0.0157	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CCBL1—kidney cancer	0.00192	0.0148	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.0019	0.0146	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PPAT—kidney cancer	0.00182	0.014	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GLIPR1—kidney cancer	0.00182	0.014	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.0018	0.0138	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00178	0.0137	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00174	0.0134	CbGpPWpGaD
Miglustat—GBA2—Metabolism—APRT—kidney cancer	0.00169	0.013	CbGpPWpGaD
Miglustat—GBA2—Metabolism—FH—kidney cancer	0.00169	0.013	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PPAT—kidney cancer	0.00166	0.0128	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GLIPR1—kidney cancer	0.00166	0.0128	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00165	0.0127	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.00164	0.0126	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00163	0.0125	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GPC3—kidney cancer	0.00159	0.0122	CbGpPWpGaD
Miglustat—UGCG—Metabolism—APRT—kidney cancer	0.00155	0.0119	CbGpPWpGaD
Miglustat—UGCG—Metabolism—FH—kidney cancer	0.00155	0.0119	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CA2—kidney cancer	0.00155	0.0119	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00151	0.0116	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ALAD—kidney cancer	0.00151	0.0116	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ST3GAL2—kidney cancer	0.00147	0.0113	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GPC3—kidney cancer	0.00145	0.0112	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ALDH1A1—kidney cancer	0.00144	0.0111	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CA2—kidney cancer	0.00141	0.0109	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ALAD—kidney cancer	0.00138	0.0106	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PGK1—kidney cancer	0.00138	0.0106	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC5A3—kidney cancer	0.00138	0.0106	CbGpPWpGaD
Miglustat—GBA2—Metabolism—LDHB—kidney cancer	0.00135	0.0104	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ST3GAL2—kidney cancer	0.00135	0.0104	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ALDH1A1—kidney cancer	0.00132	0.0101	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC5A3—kidney cancer	0.00126	0.0097	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PGK1—kidney cancer	0.00126	0.0097	CbGpPWpGaD
Miglustat—UGCG—Metabolism—LDHB—kidney cancer	0.00124	0.00951	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CA9—kidney cancer	0.00117	0.00902	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.00115	0.00881	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CA9—kidney cancer	0.00107	0.00825	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.00105	0.00806	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CRABP1—kidney cancer	0.000997	0.00767	CbGpPWpGaD
Miglustat—Muscular weakness—Capecitabine—kidney cancer	0.000976	0.00165	CcSEcCtD
Miglustat—Constipation—Erlotinib—kidney cancer	0.000975	0.00165	CcSEcCtD
Miglustat—Pain—Erlotinib—kidney cancer	0.000975	0.00165	CcSEcCtD
Miglustat—Feeling abnormal—Everolimus—kidney cancer	0.000974	0.00165	CcSEcCtD
Miglustat—Gastrointestinal pain—Vinblastine—kidney cancer	0.00097	0.00164	CcSEcCtD
Miglustat—Nervous system disorder—Sunitinib—kidney cancer	0.000968	0.00164	CcSEcCtD
Miglustat—Thrombocytopenia—Sunitinib—kidney cancer	0.000966	0.00164	CcSEcCtD
Miglustat—Gastrointestinal pain—Everolimus—kidney cancer	0.000966	0.00164	CcSEcCtD
Miglustat—Abdominal distension—Capecitabine—kidney cancer	0.000963	0.00163	CcSEcCtD
Miglustat—Discomfort—Dactinomycin—kidney cancer	0.000963	0.00163	CcSEcCtD
Miglustat—Influenza like illness—Doxorubicin—kidney cancer	0.000955	0.00162	CcSEcCtD
Miglustat—Vomiting—Pazopanib—kidney cancer	0.000952	0.00161	CcSEcCtD
Miglustat—Nausea—Temsirolimus—kidney cancer	0.000944	0.0016	CcSEcCtD
Miglustat—Anorexia—Sunitinib—kidney cancer	0.000941	0.00159	CcSEcCtD
Miglustat—Back pain—Gemcitabine—kidney cancer	0.000939	0.00159	CcSEcCtD
Miglustat—Haemoglobin—Paclitaxel—kidney cancer	0.000938	0.00159	CcSEcCtD
Miglustat—Abdominal pain—Vinblastine—kidney cancer	0.000938	0.00159	CcSEcCtD
Miglustat—Headache—Pazopanib—kidney cancer	0.000938	0.00159	CcSEcCtD
Miglustat—Abdominal pain—Everolimus—kidney cancer	0.000934	0.00158	CcSEcCtD
Miglustat—Haemorrhage—Paclitaxel—kidney cancer	0.000933	0.00158	CcSEcCtD
Miglustat—Gastrointestinal pain—Erlotinib—kidney cancer	0.000932	0.00158	CcSEcCtD
Miglustat—Hypoaesthesia—Paclitaxel—kidney cancer	0.000929	0.00157	CcSEcCtD
Miglustat—GBA2—Metabolism—ITPR2—kidney cancer	0.000927	0.00713	CbGpPWpGaD
Miglustat—Neuropathy—Doxorubicin—kidney cancer	0.000923	0.00156	CcSEcCtD
Miglustat—Vertigo—Vincristine—kidney cancer	0.000919	0.00156	CcSEcCtD
Miglustat—Connective tissue disorder—Paclitaxel—kidney cancer	0.000917	0.00155	CcSEcCtD
Miglustat—Thrombocytopenia—Dactinomycin—kidney cancer	0.000915	0.00155	CcSEcCtD
Miglustat—UGCG—Metabolism—CRABP1—kidney cancer	0.000912	0.00701	CbGpPWpGaD
Miglustat—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000903	0.00153	CcSEcCtD
Miglustat—Dyspepsia—Sorafenib—kidney cancer	0.000903	0.00153	CcSEcCtD
Miglustat—Abdominal pain—Erlotinib—kidney cancer	0.000901	0.00153	CcSEcCtD
Miglustat—Ill-defined disorder—Gemcitabine—kidney cancer	0.0009	0.00153	CcSEcCtD
Miglustat—Visual impairment—Paclitaxel—kidney cancer	0.000899	0.00152	CcSEcCtD
Miglustat—Insomnia—Sunitinib—kidney cancer	0.000893	0.00151	CcSEcCtD
Miglustat—Decreased appetite—Sorafenib—kidney cancer	0.000892	0.00151	CcSEcCtD
Miglustat—Anorexia—Dactinomycin—kidney cancer	0.000891	0.00151	CcSEcCtD
Miglustat—Nausea—Pazopanib—kidney cancer	0.000889	0.00151	CcSEcCtD
Miglustat—Paraesthesia—Sunitinib—kidney cancer	0.000886	0.0015	CcSEcCtD
Miglustat—Convulsion—Vincristine—kidney cancer	0.000886	0.0015	CcSEcCtD
Miglustat—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000886	0.0015	CcSEcCtD
Miglustat—Fatigue—Sorafenib—kidney cancer	0.000884	0.0015	CcSEcCtD
Miglustat—Constipation—Sorafenib—kidney cancer	0.000877	0.00149	CcSEcCtD
Miglustat—Pain—Sorafenib—kidney cancer	0.000877	0.00149	CcSEcCtD
Miglustat—Malaise—Gemcitabine—kidney cancer	0.000875	0.00148	CcSEcCtD
Miglustat—Eye disorder—Paclitaxel—kidney cancer	0.000872	0.00148	CcSEcCtD
Miglustat—Dyspepsia—Sunitinib—kidney cancer	0.000869	0.00147	CcSEcCtD
Miglustat—Weight decreased—Capecitabine—kidney cancer	0.000866	0.00147	CcSEcCtD
Miglustat—Decreased appetite—Sunitinib—kidney cancer	0.000858	0.00145	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000854	0.00657	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000852	0.00144	CcSEcCtD
Miglustat—Asthenia—Vinblastine—kidney cancer	0.000851	0.00144	CcSEcCtD
Miglustat—Fatigue—Sunitinib—kidney cancer	0.000851	0.00144	CcSEcCtD
Miglustat—Depression—Capecitabine—kidney cancer	0.000851	0.00144	CcSEcCtD
Miglustat—Asthenia—Everolimus—kidney cancer	0.000848	0.00144	CcSEcCtD
Miglustat—UGCG—Metabolism—ITPR2—kidney cancer	0.000847	0.00652	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ACHE—kidney cancer	0.000845	0.0065	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTT1—kidney cancer	0.000845	0.0065	CbGpPWpGaD
Miglustat—Pain—Sunitinib—kidney cancer	0.000844	0.00143	CcSEcCtD
Miglustat—Constipation—Sunitinib—kidney cancer	0.000844	0.00143	CcSEcCtD
Miglustat—Gastrointestinal pain—Sorafenib—kidney cancer	0.000839	0.00142	CcSEcCtD
Miglustat—Chills—Paclitaxel—kidney cancer	0.000837	0.00142	CcSEcCtD
Miglustat—Neuropathy peripheral—Capecitabine—kidney cancer	0.000836	0.00142	CcSEcCtD
Miglustat—Nervous system disorder—Vincristine—kidney cancer	0.000819	0.00139	CcSEcCtD
Miglustat—Asthenia—Erlotinib—kidney cancer	0.000818	0.00139	CcSEcCtD
Miglustat—Mental disorder—Paclitaxel—kidney cancer	0.000818	0.00139	CcSEcCtD
Miglustat—Thrombocytopenia—Vincristine—kidney cancer	0.000817	0.00139	CcSEcCtD
Miglustat—Discomfort—Gemcitabine—kidney cancer	0.000816	0.00138	CcSEcCtD
Miglustat—Malnutrition—Paclitaxel—kidney cancer	0.000812	0.00138	CcSEcCtD
Miglustat—Decreased appetite—Dactinomycin—kidney cancer	0.000812	0.00138	CcSEcCtD
Miglustat—Diarrhoea—Vinblastine—kidney cancer	0.000812	0.00138	CcSEcCtD
Miglustat—Abdominal pain—Sorafenib—kidney cancer	0.000811	0.00137	CcSEcCtD
Miglustat—Diarrhoea—Everolimus—kidney cancer	0.000808	0.00137	CcSEcCtD
Miglustat—Gastrointestinal pain—Sunitinib—kidney cancer	0.000807	0.00137	CcSEcCtD
Miglustat—Fatigue—Dactinomycin—kidney cancer	0.000806	0.00137	CcSEcCtD
Miglustat—Flatulence—Paclitaxel—kidney cancer	0.000801	0.00136	CcSEcCtD
Miglustat—GBA2—Metabolism—SCARB1—kidney cancer	0.0008	0.00615	CbGpPWpGaD
Miglustat—Pain—Dactinomycin—kidney cancer	0.000799	0.00135	CcSEcCtD
Miglustat—Anorexia—Vincristine—kidney cancer	0.000796	0.00135	CcSEcCtD
Miglustat—GBA2—Metabolism—PTGS1—kidney cancer	0.000792	0.00609	CbGpPWpGaD
Miglustat—Nervousness—Paclitaxel—kidney cancer	0.000789	0.00134	CcSEcCtD
Miglustat—Back pain—Paclitaxel—kidney cancer	0.000786	0.00133	CcSEcCtD
Miglustat—Dizziness—Vinblastine—kidney cancer	0.000784	0.00133	CcSEcCtD
Miglustat—Dizziness—Everolimus—kidney cancer	0.000781	0.00132	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000781	0.00601	CbGpPWpGaD
Miglustat—Muscle spasms—Paclitaxel—kidney cancer	0.000781	0.00132	CcSEcCtD
Miglustat—Abdominal pain—Sunitinib—kidney cancer	0.00078	0.00132	CcSEcCtD
Miglustat—Diarrhoea—Erlotinib—kidney cancer	0.00078	0.00132	CcSEcCtD
Miglustat—Nervous system disorder—Gemcitabine—kidney cancer	0.000777	0.00132	CcSEcCtD
Miglustat—GBA2—Metabolism—PSMD7—kidney cancer	0.000776	0.00597	CbGpPWpGaD
Miglustat—Thrombocytopenia—Gemcitabine—kidney cancer	0.000775	0.00131	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTT1—kidney cancer	0.000773	0.00595	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ACHE—kidney cancer	0.000773	0.00595	CbGpPWpGaD
Miglustat—Feeling abnormal—Dactinomycin—kidney cancer	0.00077	0.0013	CcSEcCtD
Miglustat—Haemoglobin—Capecitabine—kidney cancer	0.00077	0.0013	CcSEcCtD
Miglustat—Haemorrhage—Capecitabine—kidney cancer	0.000766	0.0013	CcSEcCtD
Miglustat—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000764	0.00129	CcSEcCtD
Miglustat—Hypoaesthesia—Capecitabine—kidney cancer	0.000762	0.00129	CcSEcCtD
Miglustat—Tremor—Paclitaxel—kidney cancer	0.000761	0.00129	CcSEcCtD
Miglustat—Insomnia—Vincristine—kidney cancer	0.000755	0.00128	CcSEcCtD
Miglustat—Anorexia—Gemcitabine—kidney cancer	0.000755	0.00128	CcSEcCtD
Miglustat—Vomiting—Vinblastine—kidney cancer	0.000754	0.00128	CcSEcCtD
Miglustat—Dizziness—Erlotinib—kidney cancer	0.000754	0.00128	CcSEcCtD
Miglustat—Ill-defined disorder—Paclitaxel—kidney cancer	0.000754	0.00128	CcSEcCtD
Miglustat—Connective tissue disorder—Capecitabine—kidney cancer	0.000753	0.00128	CcSEcCtD
Miglustat—Vomiting—Everolimus—kidney cancer	0.000751	0.00127	CcSEcCtD
Miglustat—Paraesthesia—Vincristine—kidney cancer	0.00075	0.00127	CcSEcCtD
Miglustat—Headache—Vinblastine—kidney cancer	0.000743	0.00126	CcSEcCtD
Miglustat—Headache—Everolimus—kidney cancer	0.00074	0.00125	CcSEcCtD
Miglustat—Abdominal pain—Dactinomycin—kidney cancer	0.000739	0.00125	CcSEcCtD
Miglustat—Visual impairment—Capecitabine—kidney cancer	0.000738	0.00125	CcSEcCtD
Miglustat—GBA2—Metabolism—BCHE—kidney cancer	0.000736	0.00566	CbGpPWpGaD
Miglustat—Asthenia—Sorafenib—kidney cancer	0.000736	0.00125	CcSEcCtD
Miglustat—Malaise—Paclitaxel—kidney cancer	0.000733	0.00124	CcSEcCtD
Miglustat—UGCG—Metabolism—SCARB1—kidney cancer	0.000732	0.00563	CbGpPWpGaD
Miglustat—Vertigo—Paclitaxel—kidney cancer	0.00073	0.00124	CcSEcCtD
Miglustat—GBA2—Metabolism—SLC5A5—kidney cancer	0.000727	0.00559	CbGpPWpGaD
Miglustat—Decreased appetite—Vincristine—kidney cancer	0.000726	0.00123	CcSEcCtD
Miglustat—Vomiting—Erlotinib—kidney cancer	0.000725	0.00123	CcSEcCtD
Miglustat—UGCG—Metabolism—PTGS1—kidney cancer	0.000724	0.00557	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Vincristine—kidney cancer	0.000721	0.00122	CcSEcCtD
Miglustat—Fatigue—Vincristine—kidney cancer	0.00072	0.00122	CcSEcCtD
Miglustat—Insomnia—Gemcitabine—kidney cancer	0.000716	0.00121	CcSEcCtD
Miglustat—Eye disorder—Capecitabine—kidney cancer	0.000716	0.00121	CcSEcCtD
Miglustat—Headache—Erlotinib—kidney cancer	0.000714	0.00121	CcSEcCtD
Miglustat—Pain—Vincristine—kidney cancer	0.000714	0.00121	CcSEcCtD
Miglustat—Constipation—Vincristine—kidney cancer	0.000714	0.00121	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—kidney cancer	0.000714	0.00121	CcSEcCtD
Miglustat—Paraesthesia—Gemcitabine—kidney cancer	0.000711	0.00121	CcSEcCtD
Miglustat—UGCG—Metabolism—PSMD7—kidney cancer	0.00071	0.00546	CbGpPWpGaD
Miglustat—Asthenia—Sunitinib—kidney cancer	0.000708	0.0012	CcSEcCtD
Miglustat—Nausea—Vinblastine—kidney cancer	0.000705	0.00119	CcSEcCtD
Miglustat—Convulsion—Paclitaxel—kidney cancer	0.000704	0.00119	CcSEcCtD
Miglustat—Migraine—Doxorubicin—kidney cancer	0.000702	0.00119	CcSEcCtD
Miglustat—GBA2—Metabolism—SLC2A1—kidney cancer	0.000702	0.0054	CbGpPWpGaD
Miglustat—Nausea—Everolimus—kidney cancer	0.000702	0.00119	CcSEcCtD
Miglustat—Diarrhoea—Sorafenib—kidney cancer	0.000702	0.00119	CcSEcCtD
Miglustat—Decreased appetite—Gemcitabine—kidney cancer	0.000688	0.00117	CcSEcCtD
Miglustat—Chills—Capecitabine—kidney cancer	0.000687	0.00116	CcSEcCtD
Miglustat—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000684	0.00116	CcSEcCtD
Miglustat—Discomfort—Paclitaxel—kidney cancer	0.000683	0.00116	CcSEcCtD
Miglustat—Fatigue—Gemcitabine—kidney cancer	0.000683	0.00116	CcSEcCtD
Miglustat—Gastrointestinal pain—Vincristine—kidney cancer	0.000683	0.00116	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000681	0.00524	CbGpPWpGaD
Miglustat—Dizziness—Sorafenib—kidney cancer	0.000678	0.00115	CcSEcCtD
Miglustat—Pain—Gemcitabine—kidney cancer	0.000677	0.00115	CcSEcCtD
Miglustat—Constipation—Gemcitabine—kidney cancer	0.000677	0.00115	CcSEcCtD
Miglustat—Nausea—Erlotinib—kidney cancer	0.000677	0.00115	CcSEcCtD
Miglustat—Dry mouth—Paclitaxel—kidney cancer	0.000676	0.00115	CcSEcCtD
Miglustat—Diarrhoea—Sunitinib—kidney cancer	0.000675	0.00114	CcSEcCtD
Miglustat—UGCG—Metabolism—BCHE—kidney cancer	0.000673	0.00518	CbGpPWpGaD
Miglustat—Ataxia—Doxorubicin—kidney cancer	0.000671	0.00114	CcSEcCtD
Miglustat—Mental disorder—Capecitabine—kidney cancer	0.000671	0.00114	CcSEcCtD
Miglustat—Asthenia—Dactinomycin—kidney cancer	0.00067	0.00114	CcSEcCtD
Miglustat—Malnutrition—Capecitabine—kidney cancer	0.000667	0.00113	CcSEcCtD
Miglustat—UGCG—Metabolism—SLC5A5—kidney cancer	0.000665	0.00512	CbGpPWpGaD
Miglustat—Abdominal pain—Vincristine—kidney cancer	0.00066	0.00112	CcSEcCtD
Miglustat—Flatulence—Capecitabine—kidney cancer	0.000657	0.00111	CcSEcCtD
Miglustat—Dizziness—Sunitinib—kidney cancer	0.000653	0.00111	CcSEcCtD
Miglustat—Feeling abnormal—Gemcitabine—kidney cancer	0.000653	0.00111	CcSEcCtD
Miglustat—Vomiting—Sorafenib—kidney cancer	0.000652	0.00111	CcSEcCtD
Miglustat—Abdominal pain upper—Doxorubicin—kidney cancer	0.000652	0.0011	CcSEcCtD
Miglustat—Nervous system disorder—Paclitaxel—kidney cancer	0.00065	0.0011	CcSEcCtD
Miglustat—Thrombocytopenia—Paclitaxel—kidney cancer	0.000649	0.0011	CcSEcCtD
Miglustat—Back pain—Capecitabine—kidney cancer	0.000645	0.00109	CcSEcCtD
Miglustat—Headache—Sorafenib—kidney cancer	0.000643	0.00109	CcSEcCtD
Miglustat—UGCG—Metabolism—SLC2A1—kidney cancer	0.000642	0.00494	CbGpPWpGaD
Miglustat—Muscle spasms—Capecitabine—kidney cancer	0.000641	0.00109	CcSEcCtD
Miglustat—Diarrhoea—Dactinomycin—kidney cancer	0.000639	0.00108	CcSEcCtD
Miglustat—Anorexia—Paclitaxel—kidney cancer	0.000632	0.00107	CcSEcCtD
Miglustat—Muscular weakness—Doxorubicin—kidney cancer	0.000629	0.00107	CcSEcCtD
Miglustat—Vomiting—Sunitinib—kidney cancer	0.000628	0.00106	CcSEcCtD
Miglustat—Tremor—Capecitabine—kidney cancer	0.000625	0.00106	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000623	0.00479	CbGpPWpGaD
Miglustat—Abdominal distension—Doxorubicin—kidney cancer	0.000621	0.00105	CcSEcCtD
Miglustat—Ill-defined disorder—Capecitabine—kidney cancer	0.000619	0.00105	CcSEcCtD
Miglustat—Headache—Sunitinib—kidney cancer	0.000618	0.00105	CcSEcCtD
Miglustat—Nausea—Sorafenib—kidney cancer	0.000609	0.00103	CcSEcCtD
Miglustat—Malaise—Capecitabine—kidney cancer	0.000601	0.00102	CcSEcCtD
Miglustat—Insomnia—Paclitaxel—kidney cancer	0.0006	0.00102	CcSEcCtD
Miglustat—Vertigo—Capecitabine—kidney cancer	0.000599	0.00102	CcSEcCtD
Miglustat—Asthenia—Vincristine—kidney cancer	0.000599	0.00102	CcSEcCtD
Miglustat—Paraesthesia—Paclitaxel—kidney cancer	0.000595	0.00101	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000594	0.00457	CbGpPWpGaD
Miglustat—Vomiting—Dactinomycin—kidney cancer	0.000594	0.00101	CcSEcCtD
Miglustat—Nausea—Sunitinib—kidney cancer	0.000586	0.000994	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTP1—kidney cancer	0.000586	0.00451	CbGpPWpGaD
Miglustat—Dyspepsia—Paclitaxel—kidney cancer	0.000584	0.000989	CcSEcCtD
Miglustat—Decreased appetite—Paclitaxel—kidney cancer	0.000576	0.000977	CcSEcCtD
Miglustat—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000572	0.00097	CcSEcCtD
Miglustat—Fatigue—Paclitaxel—kidney cancer	0.000572	0.000969	CcSEcCtD
Miglustat—Diarrhoea—Vincristine—kidney cancer	0.000571	0.000968	CcSEcCtD
Miglustat—Asthenia—Gemcitabine—kidney cancer	0.000568	0.000963	CcSEcCtD
Miglustat—Constipation—Paclitaxel—kidney cancer	0.000567	0.000961	CcSEcCtD
Miglustat—Pain—Paclitaxel—kidney cancer	0.000567	0.000961	CcSEcCtD
Miglustat—Discomfort—Capecitabine—kidney cancer	0.000561	0.00095	CcSEcCtD
Miglustat—Weight decreased—Doxorubicin—kidney cancer	0.000558	0.000946	CcSEcCtD
Miglustat—Dry mouth—Capecitabine—kidney cancer	0.000555	0.000941	CcSEcCtD
Miglustat—Nausea—Dactinomycin—kidney cancer	0.000555	0.000941	CcSEcCtD
Miglustat—GBA2—Metabolism—ABCB1—kidney cancer	0.000554	0.00427	CbGpPWpGaD
Miglustat—Dizziness—Vincristine—kidney cancer	0.000552	0.000936	CcSEcCtD
Miglustat—Feeling abnormal—Paclitaxel—kidney cancer	0.000546	0.000926	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000543	0.00418	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000542	0.000919	CcSEcCtD
Miglustat—Diarrhoea—Gemcitabine—kidney cancer	0.000542	0.000918	CcSEcCtD
Miglustat—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000539	0.000914	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTM1—kidney cancer	0.000538	0.00414	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTP1—kidney cancer	0.000536	0.00412	CbGpPWpGaD
Miglustat—Nervous system disorder—Capecitabine—kidney cancer	0.000534	0.000904	CcSEcCtD
Miglustat—Thrombocytopenia—Capecitabine—kidney cancer	0.000533	0.000903	CcSEcCtD
Miglustat—Vomiting—Vincristine—kidney cancer	0.000531	0.0009	CcSEcCtD
Miglustat—Abdominal pain—Paclitaxel—kidney cancer	0.000524	0.000888	CcSEcCtD
Miglustat—Headache—Vincristine—kidney cancer	0.000523	0.000886	CcSEcCtD
Miglustat—Anorexia—Capecitabine—kidney cancer	0.000519	0.000879	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP1A1—kidney cancer	0.00051	0.00393	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ABCB1—kidney cancer	0.000507	0.0039	CbGpPWpGaD
Miglustat—Vomiting—Gemcitabine—kidney cancer	0.000504	0.000853	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—kidney cancer	0.000496	0.000841	CcSEcCtD
Miglustat—Headache—Gemcitabine—kidney cancer	0.000496	0.000841	CcSEcCtD
Miglustat—Nausea—Vincristine—kidney cancer	0.000496	0.00084	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—kidney cancer	0.000494	0.000837	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTM1—kidney cancer	0.000492	0.00379	CbGpPWpGaD
Miglustat—Insomnia—Capecitabine—kidney cancer	0.000492	0.000834	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—kidney cancer	0.000491	0.000832	CcSEcCtD
Miglustat—Paraesthesia—Capecitabine—kidney cancer	0.000489	0.000828	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—kidney cancer	0.000485	0.000822	CcSEcCtD
Miglustat—Dyspepsia—Capecitabine—kidney cancer	0.000479	0.000812	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—kidney cancer	0.000476	0.000806	CcSEcCtD
Miglustat—Asthenia—Paclitaxel—kidney cancer	0.000476	0.000806	CcSEcCtD
Miglustat—Decreased appetite—Capecitabine—kidney cancer	0.000473	0.000802	CcSEcCtD
Miglustat—Nausea—Gemcitabine—kidney cancer	0.00047	0.000797	CcSEcCtD
Miglustat—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00047	0.000796	CcSEcCtD
Miglustat—Fatigue—Capecitabine—kidney cancer	0.000469	0.000795	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP1A1—kidney cancer	0.000467	0.00359	CbGpPWpGaD
Miglustat—Pain—Capecitabine—kidney cancer	0.000465	0.000789	CcSEcCtD
Miglustat—Constipation—Capecitabine—kidney cancer	0.000465	0.000789	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—kidney cancer	0.000461	0.000782	CcSEcCtD
Miglustat—Diarrhoea—Paclitaxel—kidney cancer	0.000454	0.000769	CcSEcCtD
Miglustat—Feeling abnormal—Capecitabine—kidney cancer	0.000448	0.00076	CcSEcCtD
Miglustat—Gastrointestinal pain—Capecitabine—kidney cancer	0.000445	0.000754	CcSEcCtD
Miglustat—Chills—Doxorubicin—kidney cancer	0.000443	0.000751	CcSEcCtD
Miglustat—Dizziness—Paclitaxel—kidney cancer	0.000438	0.000743	CcSEcCtD
Miglustat—Mental disorder—Doxorubicin—kidney cancer	0.000433	0.000733	CcSEcCtD
Miglustat—Abdominal pain—Capecitabine—kidney cancer	0.00043	0.000729	CcSEcCtD
Miglustat—Malnutrition—Doxorubicin—kidney cancer	0.00043	0.000728	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—kidney cancer	0.000423	0.000718	CcSEcCtD
Miglustat—Vomiting—Paclitaxel—kidney cancer	0.000422	0.000714	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.000419	0.00322	CbGpPWpGaD
Miglustat—Nervousness—Doxorubicin—kidney cancer	0.000417	0.000707	CcSEcCtD
Miglustat—Back pain—Doxorubicin—kidney cancer	0.000416	0.000705	CcSEcCtD
Miglustat—Headache—Paclitaxel—kidney cancer	0.000415	0.000704	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—kidney cancer	0.000413	0.0007	CcSEcCtD
Miglustat—Ill-defined disorder—Doxorubicin—kidney cancer	0.000399	0.000676	CcSEcCtD
Miglustat—Nausea—Paclitaxel—kidney cancer	0.000394	0.000667	CcSEcCtD
Miglustat—Asthenia—Capecitabine—kidney cancer	0.00039	0.000662	CcSEcCtD
Miglustat—Malaise—Doxorubicin—kidney cancer	0.000388	0.000657	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—kidney cancer	0.000386	0.000654	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.000383	0.00295	CbGpPWpGaD
Miglustat—GBA2—Metabolism—POMC—kidney cancer	0.00038	0.00293	CbGpPWpGaD
Miglustat—Convulsion—Doxorubicin—kidney cancer	0.000372	0.000631	CcSEcCtD
Miglustat—Diarrhoea—Capecitabine—kidney cancer	0.000372	0.000631	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—kidney cancer	0.000361	0.000613	CcSEcCtD
Miglustat—Dizziness—Capecitabine—kidney cancer	0.00036	0.00061	CcSEcCtD
Miglustat—Dry mouth—Doxorubicin—kidney cancer	0.000358	0.000606	CcSEcCtD
Miglustat—UGCG—Metabolism—POMC—kidney cancer	0.000348	0.00268	CbGpPWpGaD
Miglustat—Vomiting—Capecitabine—kidney cancer	0.000346	0.000586	CcSEcCtD
Miglustat—Nervous system disorder—Doxorubicin—kidney cancer	0.000344	0.000583	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—kidney cancer	0.000343	0.000582	CcSEcCtD
Miglustat—Headache—Capecitabine—kidney cancer	0.000341	0.000578	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—kidney cancer	0.000334	0.000567	CcSEcCtD
Miglustat—Nausea—Capecitabine—kidney cancer	0.000323	0.000548	CcSEcCtD
Miglustat—Insomnia—Doxorubicin—kidney cancer	0.000317	0.000538	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—kidney cancer	0.000315	0.000534	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—kidney cancer	0.000309	0.000523	CcSEcCtD
Miglustat—Decreased appetite—Doxorubicin—kidney cancer	0.000305	0.000517	CcSEcCtD
Miglustat—GBA2—Metabolism—PTGS2—kidney cancer	0.000303	0.00233	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000303	0.000513	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—kidney cancer	0.000302	0.000512	CcSEcCtD
Miglustat—Constipation—Doxorubicin—kidney cancer	0.0003	0.000508	CcSEcCtD
Miglustat—Pain—Doxorubicin—kidney cancer	0.0003	0.000508	CcSEcCtD
Miglustat—Feeling abnormal—Doxorubicin—kidney cancer	0.000289	0.00049	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000287	0.000486	CcSEcCtD
Miglustat—UGCG—Metabolism—PTGS2—kidney cancer	0.000278	0.00214	CbGpPWpGaD
Miglustat—Abdominal pain—Doxorubicin—kidney cancer	0.000277	0.00047	CcSEcCtD
Miglustat—GBA2—Metabolism—PTEN—kidney cancer	0.000265	0.00204	CbGpPWpGaD
Miglustat—Asthenia—Doxorubicin—kidney cancer	0.000252	0.000426	CcSEcCtD
Miglustat—UGCG—Metabolism—PTEN—kidney cancer	0.000242	0.00186	CbGpPWpGaD
Miglustat—Diarrhoea—Doxorubicin—kidney cancer	0.00024	0.000407	CcSEcCtD
Miglustat—Dizziness—Doxorubicin—kidney cancer	0.000232	0.000393	CcSEcCtD
Miglustat—Vomiting—Doxorubicin—kidney cancer	0.000223	0.000378	CcSEcCtD
Miglustat—Headache—Doxorubicin—kidney cancer	0.00022	0.000372	CcSEcCtD
Miglustat—Nausea—Doxorubicin—kidney cancer	0.000208	0.000353	CcSEcCtD
Miglustat—GBA2—Metabolism—PIK3CA—kidney cancer	0.000187	0.00144	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CA—kidney cancer	0.000171	0.00131	CbGpPWpGaD
